Risk equalization in The Netherlands: an empirical evaluation.

Expert Rev Pharmacoecon Outcomes Res

Institute of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.

Published: December 2013

The Netherlands relies on risk equalization to compensate competing health insurers for predictable variation in individual medical expenses. Without accurate risk equalization insurers are confronted with incentives for risk selection. The goal of this study is to evaluate the improvement in predictive accuracy of the Dutch risk equalization model since its introduction in 1993. Based on individual-level claims data (n = 15.6 million), we estimate the risk equalization models that have been successively applied in The Netherlands since 1993. Using individual-level survey data (n = 8735), we examine the average under-/overcompensation by these models for several relevant subgroups in the population. We find that in the course of years, the risk equalization model has been substantially improved. Even the current model (2012), however, does not eliminate incentives for risk selection completely. To achieve the public objectives, further improvement of the Dutch risk equalization model is crucial.

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2013.842127DOI Listing

Publication Analysis

Top Keywords

risk equalization
28
equalization model
12
risk
9
incentives risk
8
risk selection
8
dutch risk
8
equalization
6
equalization netherlands
4
netherlands empirical
4
empirical evaluation
4

Similar Publications

Physical activity (PA) reduces the risk of negative mental and physical health outcomes in older adults. Traditionally, PA intensity is classified using METs, with 1 MET equal to 3.5 mL O·min·kg.

View Article and Find Full Text PDF

A nested case-control study on the effect of sarcopenia on mild cognitive impairment using the CHARLS database.

Geriatr Nurs

January 2025

School of Nursing, Evidence-Based Nursing Center, Lanzhou University, Lanzhou City, Gansu Province, China. Electronic address:

Objective: This study aimed to assess the influence of sarcopenia on mild cognitive impairment (MCI) through a nationally representative survey.

Method: Participants in this nested case-control study were from the China Health and Retirement Longitudinal Study (CHARLS) cohort. In 2015, 3222 participants were included, with 2304 participants were followed up in 2018.

View Article and Find Full Text PDF

Background: The aggregation of α-synuclein protein, encoded by the SNCA gene, forms Lewy bodies (LBs) in neurons and is a key pathological feature of Lewy body dementia (LBD). Interestingly, the apolipoprotein E gene (APOE), primarily expressed in glial cells, is the strongest genetic modifier for LBD. The ε4 allele of this gene (APOE4) notably increases the risk of LBD.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) brains commonly exhibit various co-morbid pathologies, with cerebral amyloid angiopathy (CAA) being the most prevalent, affecting 70-90% of patients. CAA can be restricted to medium and large vessels or extend to capillaries. Additionally, AD patients often show pathologies involving phosphorylated-TDP-43 (pTDP-43) and alpha-synuclein (αSyn), typically demonstrating an amygdala-predominant subtype.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

UT Health San Antonio, San Antonio, TX, USA.

Background: Motivational disturbances are a major harbinger for dementia, being associated with a two- to seven-fold higher conversion rate from mild cognitive impairment. However, there are currently no objective assessment methods for identifying motivational disturbances in older adults (OA). Here, we present preliminary findings from a larger study which aims to validate an objective behavioral measure of effort in OAs by investigating the effects of age, risk, and reward (gain vs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!